Ambassador Advisors »

Xeris Pharmaceuticals shares owned by Ambassador Advisors

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Ambassador Advisors from 13F filings

Historical chart of Ambassador Advisors investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Ambassador Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Ambassador Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $838k 107k 7.85

More positions owned by Ambassador Advisors

Northern Lts Fd Tr Iv Inspire Corp Bd (IBD)
Northern Lts Fd Tr Iv Inspire Growth E (GLRY)
Ishares Gold Tr Ishares New (IAU)
Palantir Technologies Cl A (PLTR)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Etf Opportunities Trust Idx Dynamic Fixe (DYFI)
Northern Lts Fd Tr Iv Inspire Intl Etf (WWJD)
Strategy Eventide High Di (ELCV)
Xometry Class A Com (XMTR)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Etf Opportunities Trust Idx Alternative (GLDB)
Shopify Cl A Sub Vtg Shs (SHOP)
Broadcom (AVGO)
Ishares Silver Tr Ishares (SLV)

View all positions for Ambassador Advisors

Top funds holding Xeris Pharmaceuticals

BlackRock
Vanguard Group
D. E. Shaw & Co
Geode Capital Management
State Street Corporation
Qube Research & Technologies
Nuveen
Driehaus Capital Management
Rosalind Advisors
Parkman Healthcare Partners
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Legal & General Group
CenterBook Partners

View all funds holding Xeris Pharmaceuticals